Literature DB >> 21565668

Hypertension in pheochromocytoma: characteristics and treatment.

Samuel M Zuber1, Vitaly Kantorovich, Karel Pacak.   

Abstract

Pheochromocytoma is a tumor of the chromaffin cells in the adrenal medulla and sympathetic paraganglia, which synthesizes and secretes catecholamines. Norepinephrine, epinephrine, and dopamine all act on their target receptors, which causes a physiologic change in the body. High circulating levels of catecholamines can lead to severe hypertension and can have devastating effects on multiple body systems (eg, cardiovascular, cerebrovascular), and can lead to death if untreated. Although surgical treatment represents the only modality of ultimate cure, pharmacologic preoperative treatment remains the mainstay of successful outcome. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565668      PMCID: PMC3094542          DOI: 10.1016/j.ecl.2011.02.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  93 in total

1.  Innovar-induced hypertensive crises in patients with pheochromocytoma.

Authors:  D A Bittar
Journal:  Anesthesiology       Date:  1979-04       Impact factor: 7.892

Review 2.  Hypertension and the eye: changing perspectives.

Authors:  S Chatterjee; S Chattopadhyay; M Hope-Ross; P L Lip; S Chattopadhya
Journal:  J Hum Hypertens       Date:  2002-10       Impact factor: 3.012

3.  Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.

Authors:  Graeme Eisenhofer; David S Goldstein; Patricia Sullivan; Gyorgy Csako; Frederieke M Brouwers; Edwin W Lai; Karen T Adams; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2005-01-11       Impact factor: 5.958

4.  Blood pressure regulation in pheochromocytoma.

Authors:  E L Bravo; R C Tarazi; F M Fouad; S C Textor; R W Gifford; D G Vidt
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

5.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

6.  Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.

Authors:  P deS Senanayake; J Denker; E L Bravo; R M Graham
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Pheochromocytoma and pregnancy: a case report and review of anesthetic management.

Authors:  Geoff Dugas; John Fuller; Sudha Singh; James Watson
Journal:  Can J Anaesth       Date:  2004-02       Impact factor: 5.063

8.  Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas.

Authors:  N van Duinen; D Steenvoorden; I P Kema; J C Jansen; A H J T Vriends; J P Bayley; J W A Smit; J A Romijn; E P M Corssmit
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

Review 9.  The protean manifestations of pheochromocytoma.

Authors:  W M Manger
Journal:  Horm Metab Res       Date:  2009-02-25       Impact factor: 2.936

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

View more
  41 in total

Review 1.  Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.

Authors:  Roland Därr; Matthias Kuhn; Christoph Bode; Stefan R Bornstein; Karel Pacak; Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 2.  Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications.

Authors:  Agata Buonacera; Benedetta Stancanelli; Lorenzo Malatino
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-12

Review 3.  Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review.

Authors:  Rashmi Ramachandran; Vimi Rewari
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

Review 4.  PRECISION MEDICINE: AN UPDATE ON GENOTYPE/BIOCHEMICAL PHENOTYPE RELATIONSHIPS IN PHEOCHROMOCYTOMA/PARAGANGLIOMA PATIENTS.

Authors:  Garima Gupta; Karel Pacak
Journal:  Endocr Pract       Date:  2017-03-23       Impact factor: 3.443

Review 5.  Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week.

Authors:  Matthew A Nazari; Jared S Rosenblum; Mark C Haigney; Douglas R Rosing; Karel Pacak
Journal:  J Am Coll Cardiol       Date:  2020-07-28       Impact factor: 24.094

Review 6.  Labile hypertension: a new disease or a variability phenomenon?

Authors:  Elias Sanidas; Charalampos Grassos; Dimitrios P Papadopoulos; Maria Velliou; Kostas Tsioufis; Marina Mantzourani; Despoina Perrea; Dimitrios Iliopoulos; John Barbetseas; Vasilios Papademetriou
Journal:  J Hum Hypertens       Date:  2019-01-15       Impact factor: 3.012

7.  Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases.

Authors:  Akiyuki Kawashima; Masakatsu Sone; Nobuya Inagaki; Kentaro Okamoto; Mika Tsuiki; Shoichiro Izawa; Michio Otsuki; Shintaro Okamura; Takamasa Ichijo; Takuyuki Katabami; Yoshiyu Takeda; Takanobu Yoshimoto; Mitsuhide Naruse; Akiyo Tanabe
Journal:  Endocrine       Date:  2021-07-16       Impact factor: 3.633

Review 8.  Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options.

Authors:  Karren Antonio; Ma Margarita Noreen Valdez; Leilani Mercado-Asis; David Taïeb; Karel Pacak
Journal:  Gland Surg       Date:  2020-02

Review 9.  Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?

Authors:  Jenn Rachelle U Santos; Alessandra Brofferio; Bruna Viana; Karel Pacak
Journal:  Horm Metab Res       Date:  2018-09-18       Impact factor: 2.936

10.  Associations of body fat and skeletal muscle with hypertension.

Authors:  Thang S Han; Yasmin Y Al-Gindan; Lindsay Govan; Catherine R Hankey; Michael E J Lean
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.